Citizens JMP analyst Andrew Boone raised the firm’s price target on Xometry (XMTR) to $50 from $45 and keeps an Outperform rating on the shares. Xometry reported better-than-expected results as revenue and EBITDA came in above the high end of guidance, with all key performance indicators “healthy” as the company added 3.3K new Active Buyers, the analyst tells investors in a research note. With Xometry supporting its business through greater coverage of Instant Quoting and deeper integrations across manufacturers’ software and processes, growth appears to have reset in the mid-20% range after teens growth in 2024, the firm says.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XMTR:
- Xometry upgraded to Neutral from Underweight at Cantor Fitzgerald
- Xometry, Inc. Achieves Record Q2 2025 Results
- Xometry, Inc. Reports Strong Q2 Growth Amid Challenges
- Xometry’s Strong Performance and Growth Potential Justify Buy Rating
- Cantor upgrades Xometry to Neutral after Q2 beat, guidance raise